Search results
Immunity Boosting Combination Therapy for Myelodysplastic Syndrome (pre-Leukemia) Treatment: A...
Digital Journal· 2 days agoThe Company and its subsidiary BioLite, Inc. had entered into a definitive agreement with OncoX BioPharma, Inc., a private company registered in the ...
Medical College of Wisconsin Cancer Center leads research to expand Medicare coverage for HCT...
WAOW Wausau· 2 days agoMyelodysplastic syndromes (MDS) is a condition that affects bone marrow and ability to produce...
Faron Pharmaceuticals reports positive data from MDS trial
Clinical Trials Arena via Yahoo Finance· 5 days agoFaron Pharmaceuticals has announced initial positive data from the Phase II segment of the ongoing...
PISD mourns loss of dedicated educator - Pleasanton Express
Pleasanton Express· 4 days agoPleasanton ISD educator and Director of CTE/CCMR Erica Bernal succumbed on Sunday after a courageous...
Missouri residents affected by radiation exposure push Congress to extend benefits
Utah News Dispatch via Yahoo News· 15 hours agoWASHINGTON — A fund to compensate Americans sickened by exposure to atomic bomb tests, uranium...
ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug...
NBC 17 Raleigh· 2 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that its ...
Syros Pharmaceuticals (NASDAQ:SYRS) Stock Rating Reaffirmed by HC Wainwright
ETF DAILY NEWS· 7 days agoHC Wainwright restated their buy rating on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) in a report issued on Wednesday, Benzinga reports. The firm currently has a $15.00 price ...
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells - Leukemia
Nature· 4 days agoMyelodysplastic syndromes (MDS) are malignant bone marrow disorders characterized by ineffective hematopoiesis leading to refractory cytopenias and an increased ...
Newswise Expert | Namrata Chandhok, University of Miami Health System, Miller School of Medicine
Newswise· 5 days agoNamrata Chandhok, M.D. is an Assistant Professor of Clinical Medicine (Hematology) at the University of Miami Miller School of Medicine/ Sylvester Comprehensive Cancer Center. Dr. Chandhok specializes ...
Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
FOX21 Colorado Springs· 2 days agoOral presentation of final five-year results from the registrational Phase 2 trial in R/R mIDH1 AML patients reinforces REZLIDHIA® (olutasidenib) efficacy in heavily pretreated patients, including ...